Drugs / MITEMCINAL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00050882 | — | gastroparesis | Chugai Pharma USA | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MITEMCINAL | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110756 ↗ |
| Known as | 115-8543 JAPAN | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110756 ↗ |
| Known as | 5-1 UKIMA 5 CHOME | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110756 ↗ |
| Known as | GM-611 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00050882 ↗ |
| Known as | KITA-KU TOYKO | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110756 ↗ |
| Known as | MITEMCINAL FUMARATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2110756 ↗ |
| Action | Activate | “Motilin receptor agonist” CHEMBL2110756 ↗ |
| Modality | Small molecule | — CHEMBL2110756 ↗ |
| Route | Oral | “oral tablets given twice a day” NCT00050882 ↗ |
| Target | MLNR | “Motilin receptor agonist” CHEMBL2110756 ↗ |